03:21:18South Africa

iSpecimen Inc. (ISPC)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
1,928,998 -79.2%
Net income
-10,487,532
Operating income
-8,977,919
Earnings per share
-2.28

Growth and profitability

Operating margin
-465.42
Net margin
-543.68
Return on equity
-339.60
Return on assets
-110.03
Free cash flow margin
-219.86

Balance sheet

Total assets
9,531,410
Total liabilities
6,443,179
Shareholders' equity
3,088,231
Cash and equivalents
6,880,835
Current ratio
1.12

Cash flow and ratios

Operating cash flow
-4,240,608
Free cash flow
-4,241,062

Shareholder returns

Shares outstanding
2,518,590
Book value per share
1.23
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Woburn, MA
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Services-Commercial Physical & Biological Research

Fiscal year end: · Source: SEC EDGAR

iSpecimen Inc. trades on NASDAQ under the ticker symbol ISPC. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis